On October 24, 2019 Heat Biologics, Inc. (NASDAQ:HTBX), a biopharmaceutical company developing immunotherapies designed to activate a patient’s immune system against cancer, reported that data from its ongoing Phase 2 trial of HS-110 was accepted for poster presentation at The Society for Immunotherapy of Cancer (SITC) (Free SITC Whitepaper)’s (SITC) (Free SITC Whitepaper) 34th Annual Meeting (Press release, Heat Biologics, OCT 24, 2019, View Source [SID1234542476]). This data set represents a cohort of patients who have previously received a checkpoint inhibitor for advanced NSCLC, and whose disease has subsequently progressed. The study explores the efficacy of re-challenging the immune system with nivolumab in combination with HS-110 (a T-cell activating therapy) after checkpoint inhibitor failure.
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
The poster, titled "Treating advanced non-small lung cancer (NSCLC) patients after checkpoint inhibitor treatment failure with a novel combination of Viagenpumatucel-L (HS-110) plus nivolumab," will be presented starting at 7AM Eastern Time on November 8, 2019.
The SITC (Free SITC Whitepaper) Annual Meeting is being held at the Gaylord National Hotel & Convention Center in National Harbor, Maryland on November 6-10, 2019.
About SITC (Free SITC Whitepaper) 2019
The Society for Immunotherapy of Cancer (SITC) (Free SITC Whitepaper)’s (SITC) (Free SITC Whitepaper) 34th Annual Meeting provides a multidisciplinary educational and interactive environment focused on improving outcomes for current and future patients with cancer by incorporating strategies based on basic and applied cancer immunotherapy.
The Annual Meeting consists of cutting-edge research presentations by experts in the field, both oral and poster presentations, and ample opportunity for structured and informal discussions, including important networking opportunities. In addition, the meeting includes updates on major national and international initiatives coming from academia, government and industry, as well as important society projects.
Following SITC (Free SITC Whitepaper)’s tradition of collaborating to advance the field, SITC (Free SITC Whitepaper) 2019 features sessions collaboratively-developed with reputable organizations whose missions complement and align with that of SITC (Free SITC Whitepaper)’s. The meeting will conclude with the Hot Topic Symposium, an in-depth look at an emerging topic in the field.